CoChat
Sign Up
Cited by 64

Dysfunction of Microglial STAT3 Alleviates Depressive Behavior via Neuron–Microglia Interactions

Kwon, Sun-Ho, Han, Jeong-Kyu, Choi, Moonseok, Kwon, Yong-Jin, Kim, Sung Joon, Yi, Eun Hee, Shin, Jae-Cheon, Cho, Ik-Hyun +3 more·2017·Neuropsychopharmacology
DOI 10.1038/npp.2017.93PMC PMC5561349
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/npp.2017.93

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 41

  1. Audet MC, Anisman H (2013). Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses. Front Cell Neurosci 7: 68. 23675319 PMC3650474
  2. Beurel E, Grieco SF, Jope RS (2015). Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther 148: 114–131. 25435019 PMC4340754
  3. Caldeira C, Oliveira AF, Cunha C, Vaz AR, Falcão AS, Fernandes A et al (2014). Microglia change from a reactive to an age-like phenotype with the time in culture. Front Cell Neurosci 8: 152. 24917789 PMC4040822
  4. Chabot S, Williams G, Yong VW (1997). Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b. J Clin Invest 100: 604–612. 9239408 PMC508228
  5. Chen G, Huang L-D, Jiang Y-M, Manji HK (2000). The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J Neurochem 72: 1327–1330. 10037507
  6. Chitu V, Gokhan Ş, Nandi S, Mehler MF, Stanley ER (2016). Emerging roles for CSF-1 receptor and its ligands in the nervous system. Trends Neurosci 39: 378–393. 27083478 PMC4884457
  7. Chuang DM, Wang Z, Chiu CT (2011). GSK-3 as a target for lithium-induced neuroprotection against excitotoxicity in neuronal cultures and animal models of ischemic stroke. Front Mol Neurosci 4: 15. 21886605 PMC3152742
  8. Cipriani A, Smith K, Burgess S, Carney S, Goodwin G, Geddes J (2006). Lithium versus antidepressants in the long-term treatment of unipolar affective disorder. Cochrane Database Syst Rev Cd003492. 17054174 PMC7003995
  9. Clausen BH, Lambertsen KL, Babcock AA, Holm TH, Dagnaes-Hansen F, Finsen B (2008). Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflam 5: 1–18. PMC2585073 18947400
  10. Davis LL, Kabel D, Patel D, Choate AD, Foslien-Nash C, Gurguis GN et al (1996). Valproate as an antidepressant in major depressive disorder. Psychopharmacol Bull 32: 647–652. 8993086
  11. Domino ME, Burns BJ, Silva SG, Kratochvil CJ, Vitiello B, Reinecke MA et al (2008). Cost-effectiveness of treatments for adolescent depression: results from TADS. Am J Psychiatry 165: 588–596. 18413703
  12. Duman RS, Aghajanian GK, Sanacora G, Krystal JH (2016). Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med 22: 238–249. 26937618 PMC5405628
  13. Duman RS, Li N, Liu R-J, Duric V, Aghajanian G (2012b). Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 62: 35–41. 21907221 PMC3195863
  14. Dwivedi Y, Rizavi HS, Conley RR, Pandey GN (2005). ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Mol Psychiatry 11: 86–98. 16172610
  15. Dwivedi Y, Rizavi HS, Roberts RC, Conley RC, Tamminga CA, Pandey GN (2001). Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 77: 916–928. 11331420
  16. Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L et al (2003). The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 23: 7311–7316. 12917364 PMC6740453
  17. El Kasmi KC, Holst J, Coffre M, Mielke L, de Pauw A, Lhocine N et al (2006). General nature of the STAT3-activated anti-inflammatory response. J Immunol 177: 7880–7888. 17114459
  18. Fang X, Yu SX, Lu Y, Bast RC, Woodgett JR, Mills GB (2000). Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci USA 97: 11960–11965. 11035810 PMC17277
  19. Gourley SL, Wu FJ, Kiraly DD, Ploski JE, Kedves AT, Duman RS et al (2007). Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol Psychiatry 63: 353–359. 17889834 PMC2277331
  20. Hisaoka K, Takebayashi M, Tsuchioka M, Maeda N, Nakata Y, Yamawaki S (2007). Antidepressants increase glial cell line-derived neurotrophic factor production through monoamine-independent activation of protein tyrosine kinase and extracellular signal-regulated kinase in glial cells. J Pharmacol Exp Ther 321: 148–157. 17210798
  21. Hodes GE, Kana V, Menard C, Merad M, Russo SJ (2015). Neuroimmune mechanisms of depression. Nat Neurosci 18: 1386–1393. 26404713 PMC4843114
  22. Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, Zurawski SM et al (2000). Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290: 1768–1771. 11099416
  23. Imai Y, Kohsaka S (2002). Intracellular signaling in M-CSF-induced microglia activation: Role of Iba1. Glia 40: 164–174. 12379904
  24. Jope RS, Roh M-S (2006). Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets 7: 1421–1434. 17100582 PMC1850891
  25. Kamat PK, Kalani A, Tyagi N (2014). Method and validation of synaptosomal preparation for isolation of synaptic membrane proteins from rat brain. MethodsX 1: 102–107. 25250220 PMC4169895
  26. Karege F, Perroud N, Burkhardt S, Schwald M, Ballmann E, La Harpe R et al (2007). Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims. Biol Psychiatry 61: 240–245. 16876135
  27. Khairova RA, Machado-Vieira R, Du J, Manji HK (2009). A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol 12: 561–578. 19224657 PMC2771334
  28. Kong E, Sucic S, Monje FJ, Reisinger SN, Savalli G, Diao W et al (2015). STAT3 controls IL6-dependent regulation of serotonin transporter function and depression-like behavior. Scientific Reports 5: 9009. 25760924 PMC5390910
  29. Kushner SA, Elgersma Y, Murphy GG, Jaarsma D, van Woerden GM, Hojjati MR et al (2005). Modulation of presynaptic plasticity and learning by the H-ras/extracellular signal-regulated kinase/synapsin I signaling pathway. J Neurosci 25: 9721–9734. 16237176 PMC2802213
  30. Obata K, Yamanaka H, Dai Y, Tachibana T, Fukuoka T, Tokunaga A et al (2003). Differential activation of extracellular signal-regulated protein kinase in primary afferent neurons regulates brain-derived neurotrophic factor expression after peripheral inflammation and nerve injury. J Neurosci 23: 4117–4126. 12764099 PMC6741084
  31. Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I (1999). Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology 147: 162–167. 10591883
  32. Park KH, Lee TH, Kim CW, Kim J (2013). Enhancement of CCL15 expression and monocyte adhesion to endothelial cells (ECs) after hypoxia/reoxygenation and induction of ICAM-1 expression by CCL15 via the JAK2/STAT3 pathway in ECs. J Immunol 190: 6550–6558. 23690481
  33. Rajavashisth TB, Yamada H, Mishra NK (1995). Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL. Arterioscler Thromb Vasc Biol 15: 1591. 7583532
  34. Riazi K, Galic MA, Kuzmiski JB, Ho W, Sharkey KA, Pittman QJ (2008). Microglial activation and TNFα production mediate altered CNS excitability following peripheral inflammation. Proc Natl Acad Sci USA 105: 17151–17156. 18955701 PMC2579393
  35. Riley JK, Takeda K, Akira S, Schreiber RD (1999). Interleukin-10 receptor signaling through the JAK-STAT pathway: requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem 274: 16513–16521. 10347215
  36. Rogers JT, Morganti JM, Bachstetter AD, Hudson CE, Peters MM, Grimmig BA et al (2011). CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J Neurosci 31: 16241–16250. 22072675 PMC3236509
  37. Scianni M, Antonilli L, Chece G, Cristalli G, Di Castro MA, Limatola C et al (2013). Fractalkine (CX3CL1) enhances hippocampal N-methyl-d-aspartate receptor (NMDAR) function via d-serine and adenosine receptor type A2 (A2AR) activity. J Neuroinflam 10: 876. PMC3765929 23981568
  38. Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein H-G, Sarnyai Z et al (2011). Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflam 8: 1–9. PMC3177898 21831269
  39. Strekalova T, Spanagel R, Bartsch D, Henn FA, Gass P (2004). Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology 29: 2007–2017. 15266352
  40. Wake H, Moorhouse AJ, Miyamoto A, Nabekura J (2013). Microglia: actively surveying and shaping neuronal circuit structure and function. Trends Neurosci 36: 209–217. 23260014
  41. Zhan Y, Paolicelli RC, Sforazzini F, Weinhard L, Bolasco G, Pagani F et al (2014). Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat Neurosci 17: 400–406. 24487234

Cited by

Sorted by citations

Authors
Kwon, S.-H., Han, J.-K., Choi, M., Kwon, Y.-J., Kim, S. J., Yi, E. H., Shin, J.-C., Cho, I.-H., Kim, B.-H., Jeong Kim, S., & Ye, S.-K.
Venue
Neuropsychopharmacology
Publisher
Springer Science and Business Media LLC
Published
2017-05-08
Volume
42
Issue
10
Pages
2072-2086
ISSN
  • 0893-133X
  • 1740-634X
DOI
10.1038/npp.2017.93
PMC
PMC5561349
Cited by
64
References
11
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review